These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6864441)

  • 21. Jack bean urease (EC 3.5.1.5). Demonstration of a carbamoyl-transfer reaction and inhibition by hydroxamic acids.
    Blakeley RL; Hinds JA; Kunze HE; Webb EC; Zerner B
    Biochemistry; 1969 May; 8(5):1991-2000. PubMed ID: 5785219
    [No Abstract]   [Full Text] [Related]  

  • 22. T-strain mycoplasmas and genital chlamydiae: inhibition of T-strain urease by hydroxamic acids.
    Ford DK
    J Infect Dis; 1973 Mar; 127():Suppl:S82-3. PubMed ID: 4689632
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of hydroxamic acids on growth and urease activity in Corynebacterium renale.
    Nervig RM; Kadis S
    Can J Microbiol; 1976 Apr; 22(4):544-54. PubMed ID: 1260545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The enthalpimetric determination of inhibition constants for the inhibition of urease by acetohydroxamic acid.
    Zaborska W; Leszko M; Kot M; Juszkiewicz A
    Acta Biochim Pol; 1997; 44(1):89-98. PubMed ID: 9241359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of growth of T-strain mycoplasmas by hydroxamic acids and by aurothiomalate.
    Ford DK
    Antimicrob Agents Chemother; 1972 Nov; 2(5):340-3. PubMed ID: 4207956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S.E.M. study of urease-induced crystalluria in the presence of hydroxamic derivatives.
    Ben Amar M; L'Espérance G; Tawashi R
    Int Urol Nephrol; 1986; 18(3):227-33. PubMed ID: 3771124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy for urolithiasis with hydroxamic acids. IV. Prevention of infected urinary stone formation with N-(pivaloyl)glycinohydroxamic acid.
    Satoh M; Munakata K; Kitoh K; Seto N; Kanazawa T; Takeuchi H; Yoshida O
    J Pharmacobiodyn; 1981 Jul; 4(7):469-74. PubMed ID: 7028944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urease activity of Helicobacter pylori.
    Kobashi K
    J Clin Pathol; 1992 Apr; 45(4):367-8. PubMed ID: 1577984
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro inhibition of rumen urease with acetohydroxamic acid.
    Brent BE; Adepoju A; Portela F
    J Anim Sci; 1971 Apr; 32(4):794-8. PubMed ID: 5571567
    [No Abstract]   [Full Text] [Related]  

  • 30. Design, synthesis, molecular docking, anti-Proteus mirabilis and urease inhibition of new fluoroquinolone carboxylic acid derivatives.
    Abdullah MA; Abuo-Rahma GE; Abdelhafez EM; Hassan HA; Abd El-Baky RM
    Bioorg Chem; 2017 Feb; 70():1-11. PubMed ID: 27908539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening system for urease inhibitors using 13C-NMR.
    Chiyoda T; Iida K; Takatori K; Kajiwara M
    Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):718-20. PubMed ID: 9579048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of O-methyl and O-ethyl NSAID hydroxamic acids.
    Rajić Z; Perković I; Butula I; Zorc B; Hadjipavlou-Litina D; Pontiki E; Pepeljnjak S; Kosalec I
    J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1179-87. PubMed ID: 19772490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Jack bean urease (EC 3.5.1.5). IV. The molecular size and the mechanism of inhibition by hydroxamic acids. Spectrophotometric titration of enzymes with reversible inhibitors.
    Dixon NE; Hinds JA; Fihelly AK; Gazzola C; Winzor DJ; Blakeley RL; Zerner B
    Can J Biochem; 1980 Dec; 58(12):1323-34. PubMed ID: 7248834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of caprylohydroxamic acid on ruminal urease.
    Shimbayashi K; Obara Y; Yonemura T; Deguchi N; Nakanishi M
    Nihon Juigaku Zasshi; 1973 Aug; 35(4):327-34. PubMed ID: 4797147
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemistry and mechanism of urease inhibition.
    Amtul Z; Rahman AU; Siddiqui RA; Choudhary MI
    Curr Med Chem; 2002 Jul; 9(14):1323-48. PubMed ID: 12132990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, crystal structures, and urease inhibition of an acetohydroxamate-coordinated oxovanadium(V) complex derived from N'-(3-bromo-2-hydroxybenzylidene)-4-methoxybenzohydrazide.
    Qu D; Niu F; Zhao X; Yan KX; Ye YT; Wang J; Zhang M; You Z
    Bioorg Med Chem; 2015 May; 23(9):1944-9. PubMed ID: 25840795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of bacterial urease.
    Griffith DP; Musher DM; Campbell JW
    Invest Urol; 1973 Nov; 11(3):234-8. PubMed ID: 4201416
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of acetohydroxamic acid on rumen urease activity in vitro.
    Makkar HP; Sharma OP; Dawra RK; Negi SS
    J Dairy Sci; 1981 Apr; 64(4):643-8. PubMed ID: 7264024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urease inhibitors for hepatic coma. II. Comparative efficacy of four lower hydroxamate homologs in vitro and in vivo.
    Fishbein WN; Daly JE
    Proc Soc Exp Biol Med; 1970 Sep; 134(4):1083-90. PubMed ID: 5457735
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of urease inhibition on calculus formation and caries development in the rat.
    Regolati B; Mühlemann HR
    Helv Odontol Acta; 1971 Oct; 15(2):Suppl 7:147-50. PubMed ID: 4941461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.